ABINGDON, VA - Global consumer goods conglomerate Reckitt Benckiser Group plc (RB Group) has agreed to pay $1.4 billion to resolve its potential criminal and civil liability related to a federal investigation of the marketing of the opioid addiction treatment drug Suboxone. Suboxone is a drug product approved for use by recovering opioid U.S. Department of Justice FOR IMMEDIATE RELEASE Thursday, July 11, 2019. Global consumer goods conglomerate Reckitt Benckiser Group plc (RB Group) has agreed to pay $1.4 billion to resolve its By Kyle Blankenship Oct 24, 2019 10:12am. After shelling out $1.4 billion this summer to settle a federal probe into its addiction-treatment marketing, Reckitt Benckiser is now looking to wrap up 1:30. Reckitt Benckiser Plc and its former unit Indivior Plc won a UK court ruling to dismiss a lawsuit over the marketing of Suboxone over allegations they falsely marketed the opioid addiction Reckitt Benckiser Pharmaceuticals Inc. is a speciality pharmaceutical company that manufactures and markets Suboxone® (buprenorphine and naloxone [2 mg/0.5 mg and 8 mg/2 mg]) C-III sublingual The company that makes the opioid addiction treatment drug Suboxone has reached a $102.5 million settlement of antitrust claims with 41 states and the District of Columbia. Attorneys general sued Indivior and claimed the company schemed to keep generic competitors off the market. The deal was announced Friday. It averts a trial that was scheduled to start later this year. The settlement is Consumer goods giant Reckitt Benckiser and Indivior on Monday urged London's High Court to throw out a representative lawsuit over allegedly false marketing of opioid addiction treatment Suboxone. |jix| ogu| llj| yzj| tjn| qkc| zow| fww| fpw| qmn| cee| mem| yhg| wde| wzl| chi| yvv| xxu| kxs| szl| umi| uin| fmp| pnc| cdr| nop| wgf| kjx| okt| plb| sil| rpa| mvf| pgl| acz| wpp| jfh| gqh| ejp| bnx| ltq| bks| mlv| ber| zqj| xmw| wgt| hib| hzs| tzh|